List Title | APhA DrugInfoLine

Neurology

SORT BY: Most Recent Most Viewed

September 24, 2019

New guidelines on preventing and treating migraines in children and adolescents

READ

PREVIEW
The American Academy of Neurology (AAN) and American Headache Society (AHS) released updated guidelines in Neurology on acute management and prevention of headache in children and...
September 17, 2019

Some diabetic neuropathy medications are associated with falls in older adults

READ

PREVIEW
Use of tricyclic antidepressants (TCAs) or gabapentinoids increased the risk of falls and fractures in older adults with diabetic peripheral neuropathy (DPN), according to results of an...
August 20, 2019

Exposure to anticholinergic drugs may increase the risk of dementia

READ

PREVIEW
Commonly used anticholinergic drugs were associated with an increased risk of dementia in older adults, according to a study published in JAMA Internal Medicine.
July 2, 2019

AAN releases practice guideline on management of tics

READ

PREVIEW
The American Academy of Neurology (AAN) published in Neurology a guideline on management of tics in patients with Tourette syndrome and chronic tic disorders that focuses on behavioral...
June 18, 2019

Erenumab may reduce overuse of pain medications for chronic migraines

READ

PREVIEW
Use of once-monthly erenumab (Aimovig—Amgen, Novartis) in patients with chronic migraine who overused medications resulted in a greater reduction in migraine days and acute migraine-specific...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.